Related Experiment Videos
Neuropeptide Y and cardiovascular regulation
1School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.
Clinical and Experimental Pharmacology & Physiology
|January 1, 1991
Summary
Neuropeptide Y (NPY) and its fragments increase blood pressure and reduce heart vagal activity in rats. These findings suggest the existence of two distinct NPY receptor populations, impacting cardiovascular regulation.
Area of Science:
- Cardiovascular physiology
- Neuroendocrinology
- Pharmacology
Background:
- Neuropeptide Y (NPY) is a peptide involved in regulating various physiological processes, including blood pressure and autonomic function.
- Understanding the specific roles of NPY and its fragments is crucial for elucidating cardiovascular control mechanisms.
Purpose of the Study:
- To compare the effects of NPY and its related peptide fragments on blood pressure and cardiac vagal activity in anesthetized rats.
- To investigate the receptor populations mediating the cardiovascular actions of NPY.
Main Methods:
- Administration of NPY, NPY-(13-36), and a stabilized analogue (ANA NPY) to anesthetized rats.
- Measurement of blood pressure changes as an indicator of postsynaptic activity.
- Assessment of vagal activity changes as a measure of presynaptic activity.
Main Results:
- All tested peptides, including NPY, NPY-(13-36), and ANA NPY, induced pressor effects (increased blood pressure).
- These peptides also attenuated vagal action at the heart, indicating modulation of cardiac autonomic control.
- Differential potencies for pressor and vagal inhibitory actions were observed among the peptides.
Conclusions:
- The distinct potencies suggest the involvement of multiple NPY receptor populations.
- The findings support the hypothesis of at least two distinct NPY receptor populations mediating cardiovascular effects.
- This research provides insights into the complex pharmacology of NPY in cardiovascular regulation.